NASDAQ: KMPH       Kempharm Inc
Last Price Today's Change   Day's Range   Trading Volume
4.66   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):337,802
4 Weeks Range:4.03 - 4.89
4 Weeks Price Volatility (%):
52 Weeks Range:4.00 - 13.55
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

KemPharm Inc is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that believe will be improved versions of widely prescribed, approved drugs. The company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. Its LAT platform technology discovers and develops prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability, and safety. KemPharm's two lead product candidates are KP415, ER d-threo-methylphenidate product candidate for the treatment of ADHD, and KP201/IR, APAP-free, single-entity, benzhydrocodone hydrochloride IR abuse-deterrent product candidate designed for the treatment of acute pain.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2024  2255  285  7747 

Top 10 Active Counters
 ISBC 13.87-0.35 
 DIDI 2.29-0.07 
 ENDP 0.391-0.132 
 CERN 94.920.00 
 AMD 76.03-1.96 
 AMZN 104.38-4.54 
 ENIA 4.81-0.24 
 CCL 8.22-0.65 
 AAPL 135.28-3.95 
 FB 196.64+0.99